UNITED THERAPEUTICS news, videos and press releases
For more news please use our advanced search feature.
UNITED THERAPEUTICS - More news...
UNITED THERAPEUTICS - More news...
- Shareholder Alert: Ademi LLP investigates whether Miromatrix Medical Inc. has obtained a Fair Price in its transaction with United Therapeutics
- United Therapeutics to Acquire Miromatrix Medical
- United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
- United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023
- United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
- United Therapeutics Unveils Net Zero Energy Distribution Center
- United Therapeutics Corporation Reports First Quarter 2023 Financial Results
- United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
- United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
- United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
- United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
- United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
- United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
- United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
- United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
- United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
- United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
- United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
- United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
- United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
- United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
- United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022
- United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
- United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022
- United Therapeutics Provides an Update on Its Organ Printing Programs
- United Therapeutics Corporation to Present at the Jefferies Healthcare Conference
- United Therapeutics Announces FDA Approval of Tyvaso DPI™
- United Therapeutics Corporation Reports First Quarter 2022 Financial Results
